Clinical bottom line
Pediatric acute headache, including migraine and tension-type headache, is a common complaint in primary care. Evidence supports a cautious, stepwise approach emphasizing accurate diagnosis, non-opioid analgesics, and behavioral interventions while avoiding opioids and barbiturates as first-line treatments. Early identification of red flags and appropriate referral are essential. Current evidence highlights the need for integrated, evidence-based management strategies tailored to pediatric patients to improve outcomes and reduce unnecessary medication exposure (Seng et al., 2019; Gabbay et al., 2023).
What the evidence shows
Acute headache in children presents a diagnostic challenge in primary care, where most cases are benign but require differentiation from secondary causes. Gabbay et al. (2023) emphasize that migraine is the most frequent primary headache disorder in pediatric populations, but tension-type headaches are also prevalent. Accurate history-taking and clinical examination remain the cornerstone of diagnosis, with neuroimaging reserved for cases with concerning features.
Seng et al. (2019) conducted a retrospective observational study analyzing health system data and found that opioids and barbiturates are still occasionally prescribed for pediatric migraine and primary headache despite evidence advising against their use due to risks of dependence and adverse effects. Instead, first-line acute treatment should prioritize acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs), which have demonstrated efficacy and safety in children.
Behavioral and non-pharmacological interventions, including cognitive-behavioral therapy and lifestyle modifications (hydration, sleep hygiene, stress management), are increasingly recognized as integral components of headache management in pediatric primary care (Lancaster et al., 2024). These approaches can reduce headache frequency and severity, potentially decreasing reliance on medications.
Leech et al. (2006) and Martin et al. (1998), though older, provide foundational evidence supporting a biopsychosocial model in headache management, advocating for individualized care plans and family education. This remains relevant given the chronic and recurrent nature of many pediatric headaches.
Integrated care models that combine medical and behavioral health services in pediatric primary care settings may improve adherence to evidence-based practices and patient outcomes (Lancaster et al., 2024). Such models facilitate early intervention and comprehensive management, addressing both physical and psychological contributors to headache.
Caveats and uncertainty
The evidence base for pediatric acute headache management is limited by a relative scarcity of large randomized controlled trials specifically in children, leading to reliance on adult data extrapolation and observational studies. Seng et al. (2019) highlight that prescribing patterns vary widely, reflecting gaps in guideline adherence and clinician comfort.
There is also variability in headache classification and diagnostic criteria used in primary care, which may affect treatment decisions and outcomes. Behavioral interventions, while promising, require further rigorous evaluation in diverse pediatric populations to establish standardized protocols and long-term efficacy.
Neuroimaging and specialist referral thresholds remain areas of clinical judgment with limited consensus, underscoring the importance of clinical vigilance for red flags such as neurological deficits, sudden onset, or systemic symptoms.
How this may change practice
Primary care clinicians should prioritize non-opioid analgesics as first-line treatment for pediatric acute headache and avoid opioids and barbiturates due to safety concerns (Seng et al., 2019). Emphasizing thorough clinical assessment to exclude secondary causes and educating families about headache triggers and lifestyle factors can improve management.
Incorporating behavioral health strategies and considering integrated care models may enhance treatment adherence and outcomes (Lancaster et al., 2024). Clinicians should maintain a low threshold for referral when red flags or treatment resistance occur.
Ongoing clinician education and system-level interventions to align prescribing practices with evidence-based guidelines are warranted to reduce inappropriate medication use and optimize care quality.